Jessie Anne De Bruyne Malaysia

Graduated from Sheffield University Medical School, UK (MBChB with Distinction in Surgery) Obtained the MRCP(UK) 1983-1989 House jobs followed by senior house officer and registrar rotations in Sheffield, UK Returned to Malaysia and joined the Faculty of Medicine, University Malaya as a lecturer in 1991with clinical work at the University Hospital (currently Pusat Perubatan UniversitI Malaya - PPUM) in Kuala Lumpur Currently Visiting Consultant PPUM Consultant Paediatrician & Paediatric Respiratory Physician UMSC Varied research interests primarily in asthma epidemiology and management and respiratory infection HELP (Home Equipment Loan Programme) committee, PPUM – chairperson Member or Executive Council of national and international professional and other Societies including: Malaysian Paediatric Association (member – former Honorary Secretary) Malaysian Thoracic Society (Honorary Treasurer) Asia Pacific Association of Paediatric Allergy, Respirology and Immunology (council member) Asia Pacific Society of Respirology (member, former Head of Paediatric Assembly) Asian Paediatric Respiratory Interest Group (founding member) Asian Paediatric Pulmonology Society (council member) Malaysian Society of Allergy & Immunology (founding member – former committee member) Lung Foundation of Malaysia (Board member) Children’s Asthma Club (founding member and Honorary Secretary)
Job Title
Consultant Paediatric Respiratory Physician
Faculty / Department / Division
Institution / Organisation
Universiti Malaya Medical Centre

20 November 2026, Friday

Time Session
11:00
12:00
Chee Kuan Wong Chairperson Malaysia
Fatimah Azmah Mohammad Chairperson Malaysia
  • Min Suk Yang Speaker Republic of Korea
    Asthma is not a single disease. Cluster and molecular studies consistently identify a type 2-high endotype, driven by epithelial alarmins, IL-4, IL-5 and IL-13, whereas type 2-low asthma remains poorly defined. Blood eosinophils and FeNO each predict exacerbations independently of clinical risk factors, and together identify the highest-risk patients. Because corticosteroids suppress both, low values on treatment should be repeated before a patient is labelled type 2-low. Six monoclonal antibodies target IgE, IL-5 or its receptor, IL-4Rα and TSLP. All reduce exacerbations, and several spare oral corticosteroids, yet registries show clinical remission in only one in four or five patients, and cost shapes real-world use. With no overall winner, the choice rests on predictive biomarkers and comorbidities. Beyond the blood count, CT mucus plugs, exacerbation phenotyping, molecular profiling and treatable traits are extending precision care, with remission, more likely before steroid dependence, as the goal.
  • Takao Fujisawa Speaker Japan
    Childhood wheeze encompasses heterogeneous clinical courses with different implications for subsequent asthma. Birth cohorts, including Tucson, ALSPAC, and PIAMA, have established the importance of wheeze timing and persistence. However, heterogeneity among infants who already have recurrent wheeze remains less well characterized. This presentation reviews these cohort frameworks and examines how the Phenotyping of Wheezing Infants (P-WIN) study extends trajectory analysis by incorporating episode frequency. P-WIN enrolled 253 children aged 12–23 months with recurrent wheeze across 27 Japanese sites. Monthly caregiver reports supported longitudinal assessment, and 219 children completed follow-up to age three. Latent class growth analysis of annual wheeze episode counts identified four trajectories: early resolving (24.2%), low frequency with a mid-course peak (57.1%), persistent high frequency (12.8%), and late-peaking high frequency (5.9%). The two high-frequency groups comprised 18.7% of participants and experienced greater symptom burden. Household exposures, including parental smoking, showed associations with trajectory membership, although these observational findings do not establish causality. These results demonstrate clinically relevant variation in wheeze frequency and timing within an already symptomatic population. Nevertheless, trajectory membership depends on subsequent observations, and its value for baseline prediction, treatment selection, and school-age prognosis requires validation. In relation to “The Evolving Immune Landscape,” P-WIN provides a clinical framework for future mechanistic investigation. Immune assessment was limited to routine IgE and eosinophil measurements, and the study did not identify immune endotypes. Repeated immune profiling could test how type 2 immunity and antiviral, epithelial, or neutrophilic pathways relate to evolving wheeze patterns. Integrating these measurements with longitudinal symptoms and school-age asthma and lung function outcomes may clarify the biological and prognostic significance of early wheeze trajectories.
  • Jessie Anne De Bruyne Speaker Malaysia
    Preschool wheezing and childhood asthma are common conditions which are still poorly understood due to the heterogeneity of the underlying pathological mechanisms and the time course of the disease development together with the variable connection between the two. Current diagnostic labels which have evolved over time are imprecise as clinical presentations are often similar across different underlying mechanisms and diagnostic tests are not only lacking but can be difficult in young children leading to difficulties in targeting therapy. Modern data approaches encompass machine learning (computers learning from data), artificial intelligence (smart computer systems), data science (analysing large numbers of medical records) and big data (combining blood tests, genes, clinical history, and scans). Carefully designed epidemiological and birth cohort studies have collected "big data" on a large scale, with a wealth of longitudinal clinical data and detailed information from various modalities including imaging, biomarkers, respiratory function testing among others have sought to address this conundrum of preschool wheeze and childhood asthma.
  • Q&A
Ballroom 4, Lower Ground Floor